- All sections
- C - Chemistry; metallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 275/16 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
Patent holdings for IPC class C07C 275/16
Total number of patents in this class: 130
10-year publication summary
|
9
|
7
|
11
|
10
|
15
|
12
|
9
|
17
|
5
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Johns Hopkins University | 5519 |
10 |
| Molecular Insight Pharmaceuticals, Inc. | 56 |
9 |
| Cornell University | 3184 |
5 |
| Gilead Sciences, Inc. | 1949 |
5 |
| The Regents of the University of California | 19479 |
3 |
| Board of Regents, The University of Texas System | 5604 |
3 |
| MedImmune Limited | 624 |
3 |
| Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | 89 |
3 |
| Risen (Suzhou) Pharma Tech Co., Ltd. | 64 |
3 |
| Peking University First Hospital | 26 |
3 |
| Kaneka Corporation | 4483 |
2 |
| Arcturus Therapeutics, Inc. | 164 |
2 |
| Cedars-Sinai Medical Center | 1131 |
2 |
| Exerkine Corporation | 33 |
2 |
| Osaka University | 3288 |
2 |
| Provincial Health Services Authority | 167 |
2 |
| The Scripps Research Institute | 1353 |
2 |
| Tetraphase Pharmaceuticals, Inc. | 50 |
2 |
| ThermoLife International, LLC | 113 |
2 |
| ShangPharma Innovation Inc. | 21 |
2 |
| Other owners | 63 |